A great trip to Vienna for the excellent #ERA25 and back to London in time for Robbie at the Emirates last night - what a week!

Interesting talk about fragility of AAV studies - average number of patients in whom a change in event occurrence would change the overall outcome of study is just 4 (which is less than the number of patients who are lost to follow up). #ERA25

Stimulating session on frailty and renal transplantation #ERA25 Plenty to think about and implement in the clinic

Does anyone advise patients on deceased donor renal transplant list not to take SGLT-2 inhibitors?
Seems reasonable for living donor transplant to stop pre-op but not aware of risk : benefit in those waiting for deceased donor kidney?